PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)
Clinical trial NCT02723877 · COMPLETED
Trial details
- NCT number
- NCT02723877
- Sponsor
- PIQUR Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-28
- Primary completion
- 2018-10-03
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.